KAM
Krensavage Asset Management’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-108,923
| Closed | -$16.7M | – | 15 |
|
2024
Q4 | $16.7M | Sell |
108,923
-4,579
| -4% | -$700K | 9.85% | 4 |
|
2024
Q3 | $22M | Sell |
113,502
-10,283
| -8% | -$1.99M | 12.33% | 4 |
|
2024
Q2 | $28.7M | Sell |
123,785
-10,283
| -8% | -$2.38M | 13.18% | 3 |
|
2024
Q1 | $28.9M | Sell |
134,068
-26,412
| -16% | -$5.7M | 12.82% | 3 |
|
2023
Q4 | $41.5M | Hold |
160,480
| – | – | 14.73% | 3 |
|
2023
Q3 | $41.2M | Sell |
160,480
-16,346
| -9% | -$4.2M | 15.19% | 3 |
|
2023
Q2 | $50.4M | Sell |
176,826
-300
| -0.2% | -$85.5K | 15.96% | 1 |
|
2023
Q1 | $49.2M | Buy |
177,126
+122
| +0.1% | +$33.9K | 14.96% | 1 |
|
2022
Q4 | $49M | Sell |
177,004
-7,644
| -4% | -$2.12M | 15.15% | 2 |
|
2022
Q3 | $49.3M | Buy |
184,648
+67,400
| +57% | +$18M | 15.7% | 1 |
|
2022
Q2 | $23.9M | Buy |
117,248
+5,895
| +5% | +$1.2M | 7.9% | 8 |
|
2022
Q1 | $23.5M | Buy |
111,353
+8,300
| +8% | +$1.75M | 8.08% | 8 |
|
2021
Q4 | $24.7M | Sell |
103,053
-149
| -0.1% | -$35.7K | 8.58% | 8 |
|
2021
Q3 | $29.2M | Buy |
103,202
+5,679
| +6% | +$1.61M | 9.16% | 7 |
|
2021
Q2 | $33.8M | Sell |
97,523
-40,995
| -30% | -$14.2M | 11.46% | 6 |
|
2021
Q1 | $38.8M | Buy |
138,518
+501
| +0.4% | +$140K | 13.41% | 5 |
|
2020
Q4 | $33.8M | Buy |
138,017
+854
| +0.6% | +$209K | 9.87% | 6 |
|
2020
Q3 | $38.9M | Sell |
137,163
-14,257
| -9% | -$4.04M | 12.39% | 4 |
|
2020
Q2 | $40.5M | Buy |
151,420
+40,649
| +37% | +$10.9M | 11.02% | 4 |
|
2020
Q1 | $35M | Buy |
110,771
+867
| +0.8% | +$274K | 11.27% | 5 |
|
2019
Q4 | $32.6M | Sell |
109,904
-66,806
| -38% | -$19.8M | 11.13% | 5 |
|
2019
Q3 | $41.1M | Buy |
176,710
+154
| +0.1% | +$35.9K | 15.8% | 2 |
|
2019
Q2 | $41.3M | Sell |
176,556
-3,444
| -2% | -$805K | 13.4% | 3 |
|
2019
Q1 | $42.5M | Buy |
+180,000
| New | +$42.5M | 11.5% | 4 |
|